首页|中医药核心指标集报告质量评价

中医药核心指标集报告质量评价

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
目的:评价已公开发表的中医药核心指标集(COS)的报告质量.方法:全面检索中国知网、万方数据库、中国生物医学文献数据库、PubMed、EMbase所发表的中医药COS,检索时限为建库至2022年4月30日.采用核心指标集报告规范(COS-STAR)清单评价和分析所有纳入的文献.将获得的相关数据录入Excel软件,进行统计分析.结果:共纳入中医药COS研究8篇,研究者主要集中在北京、天津、广州3个地区,3篇(37.5％)中医药CoS无中医相关指标;2篇(25.0％)描述了COS涉及的健康问题和人群以及COS涉及的干预措施,1篇(12.5％)准确描述COS适用条件;分别有5篇(62.5％)、5篇(62.5％)、4篇(50.0％)完整描述了共识执行过程、达成共识的标准、共识过程中纳入排除指标的标准.结论:已发布的中医药COS报告质量有待进一步提高,合理利用COS-STAR声明将有助于提高中医药COS的报告质量.
Reporting quality evaluation of core outcome set for traditional Chinese medicine
Objective:To assess the reporting quality of core outcome set(COS)for traditional Chinese medicine(TCM)by core outcome set-standards for reporting(COS-STAR)statement.Methods:The COSs for TCM were searched in database of CNKI,Wanfang,SinoMed,PubMed and Embase from its inception to 2022 April 30th.The quality of the included studies was assessed in accordance with the COS-STAR statement.The data were put into Excel for statistical analysis.Results:Among all literature,a total of 8 studies were included.The authors are located in Beijing,Tianjin and Guangzhou.No traditional Chinese medicine related outcomes included in 3(37.5％)COSs for TCM.Consensus process were completely reported in 5 studies(62.5％),consensus criteria were reported in 5 studies(62.5％),eligible criteria of outcomes were reported in 4 studies(50.0％).Conclusion:The overall reporting quality of COSs for TCM is poor,and the reasonable utilization of the COS-STAR statement will improve the reporting quality of COSs in TCM.

Traditional Chinese medicineCore outcome setReporting qualityCOS-STAR statement

邢冬梅、刘志斌、李春晓、张俊华、朱明军

展开 >

河南中医药大学第一附属医院,郑州 450000

天津中医药大学,天津 301617

中医药 核心指标集 报告质量 COS-STAR声明

国家自然科学基金2020年河南省青年人才托举工程项目河南省中医管理局国家中医临床研究基地科研专项河南省高等学校重点科研项目国家重点研发计划中医药现代化研究重点专项国家重点研发计划中医药现代化研究重点专项

817038892020HYTP0602022JDZX07719A3600152019YFC17100002019YFC1710003

2024

中华中医药杂志
中华中医药学会

中华中医药杂志

CSTPCD北大核心
影响因子：1.135
ISSN：1673-1727
年,卷(期)：2024.39(1)
  • 15